CLINICAL_TRIALS
trial_result
· 2024-10-28
Clinical Trial Update: Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes [Phase 3]
Summary
This Phase 3 trial evaluating semaglutide for obesity with prediabetes has completed and its results were posted on 2024-10-28.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2024-10-28